Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Pain. 2017 Jun;158(6):1069–1082. doi: 10.1097/j.pain.0000000000000886

Table 5.

Medication use by category for 3-month pain symptom change trend improvers and non-improvers at the baseline and 8-week assessment.

Baseline Assessment 8-week Assessment
Treatment 3 month
Improvers
N=26
3 month
Non-Improvers
N=26
p-value 3 month
Improvers
N=26
3 month
Non-Improvers
N=26
p-value
Alphablockers 3 1 0.60 0 0 1.0
Benzodiazepines 1 1 1.0 0 0 1.0
Anticholinergics 1 2 1.0 0 1 1.0
Elmiron 1 2 1.0 0 0 1.0
Gabapentinoids 1 1 1.0 1 1 1.0
Antihistamines 0 1 1.0 0 0 1.0
Bladder instillation 1 1 1.0 0 0 1.0
NSAIDs 6 4 0.24 3 1 0.68
Opioids 2 4 0.66 1 0 1.0
Pelvic floor physical therapy 4 6 0.72 2 2 1.0
NSRIs 0 0 1.0 1 1 1.0
SSRIs 0 0 1.0 0 0 1.0
Tricyclic antidepressants 2 5 0.41 2 3 1.0
Antibiotics/antifungals 0 1 1.0 0 0 1.0